marie-rolland

26 February 2018
Pharmablue
Rare diseases: At the core of our mission At PharmaBlue, we’ve spent the past decade...
Known as Expanded Access Programs in the US, early access programs (EAP) allow access to...
About the "Exploitant" status French regulatory authorities require having an « Exploitant » authorized and...